As of June 18, 2025, AquaBounty Technologies Inc (AQB) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing AquaBounty Technologies Inc's Forward P/E to Peers
To better understand AquaBounty Technologies Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| AquaBounty Technologies Inc (AQB) | - |
| MeiraGTx Holdings PLC (MGTX) | 267.80 |
| Vertex Pharmaceuticals Inc (VRTX) | 24.69 |
| Abbvie Inc (ABBV) | 15.12 |
| Regeneron Pharmaceuticals Inc (REGN) | 14.37 |
| Amgen Inc (AMGN) | 14.05 |
Compared to its competitors, AquaBounty Technologies Inc's Forward P/E is difficult to compare due to insufficient data.